NR606 Final Verified Multiple Choice and
Conceptual Actual Emended Exam Questions
With Reviewed 100% Correct Detailed Answers
Guaranteed Pass!!Current Update
1. What is the gold standard for diagnosing COPD?
a) Chest X-ray
b) Spirometry
c) Pulse oximetry
d) Arterial blood gas
Answer: b) Spirometry
Rationale: Spirometry confirming irreversible airflow obstruction (FEV1/FVC <0.70
post-bronchodilator) is the diagnostic standard for COPD.
2. A 56-year-old with increasing SOB has a CXR showing flattened diaphragms and
enlarged retrosternal space. What is the most likely diagnosis?
a) Asthma
b) COPD
c) CHF
d) Pulmonary fibrosis
Answer: b) COPD
Rationale: Flattened diaphragms + enlarged retrosternal space are classic CXR
signs of emphysematous COPD.
3. You're reviewing CXR report on 56yo male who presented w/increasing SOB.
You suspect COPD. You know the dx can be made with a high degree of accuracy if
2 of the following criteria are met:
,1. Flattening of diaphragm w/blunting of costophrenic angle on PA film
2. Upper zone redistribution of pulmonary blood flow (cephalization)
3. Abnormally enlarged retrosternal space
4. Signs of interstitial edema - ANSWER 1 and 3
4. You have completed the first follow up visit for a new COPD pt who is in stable
condition. The pt asks how often he needs to follow up for COPD. You state that
stable COPD pts should return for follow up eval:
a. Yearly
b. Monthly
c. Every 3-6mo
d. Every 2mo - ANSWER C
5. Which two CXR findings together strongly support a diagnosis of COPD?
a) Upper zone redistribution and interstitial edema
b) Flattened diaphragm and enlarged retrosternal space
c) Pleural effusion and Kerley B lines
d) Infiltrates and mediastinal widening
Answer: b) Flattened diaphragm and enlarged retrosternal space
Rationale: These two findings correlate best with hyperinflation from COPD.
6. How often should stable COPD patients have follow-up visits?
a) Every month
b) Every 3–6 months
c) Yearly
d) Only as needed
Answer: b) Every 3–6 months
,Rationale: Stable COPD patients require reassessment every 3–6 months for
symptoms, inhaler technique, and exacerbation prevention.
7. A COPD patient reports frequent night-time symptoms and poor exercise
tolerance. Which tool is commonly used to assess symptom severity?
a) Beck Depression Inventory
b) COPD Assessment Test (CAT)
c) Framingham Risk Score
d) MMSE
Answer: b) COPD Assessment Test (CAT)
Rationale: The CAT is an 8-item tool to quantify COPD symptom burden and guide
management.
8. In COPD management, which lifestyle intervention has the strongest evidence
for mortality benefit?
a) Pulmonary rehabilitation
b) Smoking cessation
c) Daily exercise
d) Oxygen therapy for mild hypoxemia
Answer: b) Smoking cessation
Rationale: Smoking cessation is the single most effective intervention to slow
COPD progression.
9. Long-term oxygen therapy is indicated for COPD when PaO₂ is:
a) ≤80 mmHg
b) ≤70 mmHg with mild symptoms
c) ≤55 mmHg or O₂ sat ≤88%
d) ≤65 mmHg at rest
Answer: c) ≤55 mmHg or O₂ sat ≤88%
, Rationale: These values meet the CMS and GOLD criteria for oxygen therapy
initiation.
10. Which inhaler should NEVER be prescribed as monotherapy in COPD?
a) Short-acting beta agonist (SABA)
b) Inhaled corticosteroid (ICS)
c) Long-acting muscarinic antagonist (LAMA)
d) Long-acting beta agonist (LABA)
Answer: d) LABA
Rationale: LABAs increase mortality risk if used without an ICS in asthma; in COPD,
LABAs should be combined with other therapies for safety.
11. A patient with COPD reports increased sputum purulence, dyspnea, and
volume. What is the best management step?
a) Continue current inhaler therapy
b) Add antibiotics
c) Add oral steroids only
d) Order a DEXA scan
Answer: b) Add antibiotics
Rationale: The Anthonisen criteria (increased dyspnea, sputum volume, and
purulence) indicate bacterial infection, warranting antibiotics.
12. Which vaccine is recommended for all adults with COPD to reduce morbidity?
a) HPV
b) Pneumococcal vaccine
c) Hepatitis B vaccine
d) Varicella vaccine
Answer: b) Pneumococcal vaccine
Rationale: Both PCV15/PCV20 and PPSV23 are recommended in COPD for
pneumonia prevention.
Conceptual Actual Emended Exam Questions
With Reviewed 100% Correct Detailed Answers
Guaranteed Pass!!Current Update
1. What is the gold standard for diagnosing COPD?
a) Chest X-ray
b) Spirometry
c) Pulse oximetry
d) Arterial blood gas
Answer: b) Spirometry
Rationale: Spirometry confirming irreversible airflow obstruction (FEV1/FVC <0.70
post-bronchodilator) is the diagnostic standard for COPD.
2. A 56-year-old with increasing SOB has a CXR showing flattened diaphragms and
enlarged retrosternal space. What is the most likely diagnosis?
a) Asthma
b) COPD
c) CHF
d) Pulmonary fibrosis
Answer: b) COPD
Rationale: Flattened diaphragms + enlarged retrosternal space are classic CXR
signs of emphysematous COPD.
3. You're reviewing CXR report on 56yo male who presented w/increasing SOB.
You suspect COPD. You know the dx can be made with a high degree of accuracy if
2 of the following criteria are met:
,1. Flattening of diaphragm w/blunting of costophrenic angle on PA film
2. Upper zone redistribution of pulmonary blood flow (cephalization)
3. Abnormally enlarged retrosternal space
4. Signs of interstitial edema - ANSWER 1 and 3
4. You have completed the first follow up visit for a new COPD pt who is in stable
condition. The pt asks how often he needs to follow up for COPD. You state that
stable COPD pts should return for follow up eval:
a. Yearly
b. Monthly
c. Every 3-6mo
d. Every 2mo - ANSWER C
5. Which two CXR findings together strongly support a diagnosis of COPD?
a) Upper zone redistribution and interstitial edema
b) Flattened diaphragm and enlarged retrosternal space
c) Pleural effusion and Kerley B lines
d) Infiltrates and mediastinal widening
Answer: b) Flattened diaphragm and enlarged retrosternal space
Rationale: These two findings correlate best with hyperinflation from COPD.
6. How often should stable COPD patients have follow-up visits?
a) Every month
b) Every 3–6 months
c) Yearly
d) Only as needed
Answer: b) Every 3–6 months
,Rationale: Stable COPD patients require reassessment every 3–6 months for
symptoms, inhaler technique, and exacerbation prevention.
7. A COPD patient reports frequent night-time symptoms and poor exercise
tolerance. Which tool is commonly used to assess symptom severity?
a) Beck Depression Inventory
b) COPD Assessment Test (CAT)
c) Framingham Risk Score
d) MMSE
Answer: b) COPD Assessment Test (CAT)
Rationale: The CAT is an 8-item tool to quantify COPD symptom burden and guide
management.
8. In COPD management, which lifestyle intervention has the strongest evidence
for mortality benefit?
a) Pulmonary rehabilitation
b) Smoking cessation
c) Daily exercise
d) Oxygen therapy for mild hypoxemia
Answer: b) Smoking cessation
Rationale: Smoking cessation is the single most effective intervention to slow
COPD progression.
9. Long-term oxygen therapy is indicated for COPD when PaO₂ is:
a) ≤80 mmHg
b) ≤70 mmHg with mild symptoms
c) ≤55 mmHg or O₂ sat ≤88%
d) ≤65 mmHg at rest
Answer: c) ≤55 mmHg or O₂ sat ≤88%
, Rationale: These values meet the CMS and GOLD criteria for oxygen therapy
initiation.
10. Which inhaler should NEVER be prescribed as monotherapy in COPD?
a) Short-acting beta agonist (SABA)
b) Inhaled corticosteroid (ICS)
c) Long-acting muscarinic antagonist (LAMA)
d) Long-acting beta agonist (LABA)
Answer: d) LABA
Rationale: LABAs increase mortality risk if used without an ICS in asthma; in COPD,
LABAs should be combined with other therapies for safety.
11. A patient with COPD reports increased sputum purulence, dyspnea, and
volume. What is the best management step?
a) Continue current inhaler therapy
b) Add antibiotics
c) Add oral steroids only
d) Order a DEXA scan
Answer: b) Add antibiotics
Rationale: The Anthonisen criteria (increased dyspnea, sputum volume, and
purulence) indicate bacterial infection, warranting antibiotics.
12. Which vaccine is recommended for all adults with COPD to reduce morbidity?
a) HPV
b) Pneumococcal vaccine
c) Hepatitis B vaccine
d) Varicella vaccine
Answer: b) Pneumococcal vaccine
Rationale: Both PCV15/PCV20 and PPSV23 are recommended in COPD for
pneumonia prevention.
